Point72 Hong Kong’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
11,621
+7,609
| +190% | +$135K | 0.01% | 296 |
|
|
2025
Q1 | $71.5K | Buy |
+4,012
| New | +$71.5K | ﹤0.01% | 345 |
|
|
2024
Q4 | – | Sell |
-7,684
| Closed | -$120K | – | 542 |
|
|
2024
Q3 | $120K | Sell |
7,684
-10,940
| -59% | -$171K | 0.01% | 320 |
|
|
2024
Q2 | $319K | Buy |
18,624
+17,385
| +1,403% | +$298K | 0.02% | 271 |
|
|
2024
Q1 | $19.4K | Buy |
+1,239
| New | +$19.4K | ﹤0.01% | 476 |
|
|
2022
Q1 | – | Sell |
-4,825
| Closed | -$362K | – | 1665 |
|
|
2021
Q4 | $362K | Buy |
4,825
+3,699
| +329% | +$278K | 0.01% | 354 |
|
|
2021
Q3 | $131K | Sell |
1,126
-3,191
| -74% | -$371K | ﹤0.01% | 671 |
|
|
2021
Q2 | $958K | Buy |
+4,317
| New | +$958K | 0.03% | 287 |
|
|
2020
Q4 | – | Sell |
-3,099
| Closed | -$345K | – | 1515 |
|
|
2020
Q3 | $345K | Sell |
3,099
-406
| -12% | -$45.2K | 0.04% | 353 |
|
|
2020
Q2 | $208K | Buy |
+3,505
| New | +$208K | 0.02% | 505 |
|
|
2019
Q4 | – | Sell |
-14
| Closed | -$1K | – | 1360 |
|
|
2019
Q3 | $1K | Sell |
14
-489
| -97% | -$34.9K | ﹤0.01% | 911 |
|
|
2019
Q2 | $32K | Buy |
503
+468
| +1,337% | +$29.8K | 0.01% | 699 |
|
|
2019
Q1 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 896 |
|
|
2018
Q4 | – | Sell |
-563
| Closed | -$30K | – | 1105 |
|
|
2018
Q3 | $30K | Buy |
+563
| New | +$30K | 0.01% | 535 |
|